v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 5 Months Ended 7 Months Ended 12 Months Ended
Dec. 31, 2024
Jul. 30, 2024
Dec. 31, 2025
Financial Designation, Predecessor and Successor [Fixed List] Successor    
Cash flows from operating activities:      
Net loss $ (53,763) $ (21,278) $ (25,084)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 740 646 970
Non-cash operating lease expense 56 98  
Stock-based compensation   642 1,479
Provision for inventory impairment (4) 15  
Amortization of term loan discount   10  
Loss on disposal of property and equipment   62  
Impairment - Goodwill 30,324 0 0
Impairment - Intangibles assets, net 18,878    
Change in fair value of convertible notes payable (929) (2,059) 980
Change in fair value of warrant liabilities (6,576) (191) (20)
Net change in operating assets and liabilities:      
Accounts receivable, net 67 (32) 38
Inventory, net 1,399 (773) 931
Prepaid expenses and other current assets (886) (95) 867
Accounts payable (1,933) (2,628) (1,756)
Accrued liabilities 127 511 3,300
Accrued transaction costs 3 7,446  
Other accrued liabilities 1,001 1,734 2,877
Operating lease liabilities (56) (98) 20
Other long-term liabilities     (3,616)
Deferred taxes (1,917)    
Net cash used in operating activities (13,469) (15,990) (19,014)
Cash flows from investing activities:      
Purchases of property and equipment (1,280) (368) (374)
Net cash used in investing activities (1,280) (368) (374)
Cash flows from financing activities:      
Proceeds from the issuance of common shares, pre-funded warrants and warrants, net of $2,865 issuance costs     16,134
Proceeds from issuance of convertible notes payable   16,500  
Repayment of non-convertible term loan   (867)  
Net cash provided by financing activities   15,633 16,134
Effect of foreign currency translation on cash and cash equivalents 181 24 (227)
Net change in cash and cash equivalents (14,568) (701) (3,481)
Cash and cash equivalents, at beginning of period 35,154 1,383 20,586
Cash and cash equivalents, at end of period 20,586 35,154 $ 17,105
Supplemental disclosure of cash flow information:      
Cash paid for interest   85  
Supplemental disclosure of noncash investing and financing activities:      
Right-of-use assets obtained in exchange for lease liabilities   (216)  
Lease liabilities recorded for operating lease right-of-use assets   216  
Exchange preferred stock for pre-funded warrants   4,332  
Prior to Effect of Business Combination      
Cash flows from financing activities:      
Cash and cash equivalents, at beginning of period $ 682    
Cash and cash equivalents, at end of period   $ 682